TS
Highly rated in
5
conditions
Highly rated in
5
conditions
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Tara B. Sanft's experience treating your condition:
About Dr. Tara B. Sanft

Tara Sanft is an Oncologist and a Palliative Medicine expert in New Haven, Connecticut. Sanft has been practicing medicine for over 19 years and is highly rated in 5 conditions, according to our data. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, Breast Cancer in Men, and Gamma Knife Radiosurgery. She is licensed to treat patients in Connecticut. Sanft is currently accepting new patients.

Her clinical research consists of co-authoring 68 peer reviewed articles and participating in 5 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Tara B. Sanft it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Tara B. Sanft accepts the following insurance:

  •  Ambetter

Call to see if your plan is accepted.
Locations
35 Park St, New Haven, CT 06519
Background & Education
Graduate Institution
Medical College Of Wisconsin, 2004
Specialties
Oncology
Palliative Medicine
Licenses
Internal Medicine in CT
Hospital Affiliations
Yale New Haven Hospital
Languages Spoken
English
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

Lifestyle, Exercise, and Nutrition Study Early After Diagnosis (LEANer)
A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women With Endocrine Responsive Breast Cancer Who Desire Pregnancy
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
View 4 Less Clinical Trials -

68 Total Publications

NCCN Guidelines® Insights: Survivorship, Version 1.2022.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors